Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells

Lubica Ondrušová, Jiri Vachtenheim, Jiri Réda, Petra Žáková, Kamila Benková

. 2013 ; 8 (1) : e54110.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031682

Grantová podpora
NT11229 MZ0 CEP - Centrální evidence projektů

Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGFß2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031682
003      
CZ-PrNML
005      
20141223084714.0
007      
ta
008      
131002s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0054110 $2 doi
035    __
$a (PubMed)23349796
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ondrušová, Lubica $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
245    10
$a MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells / $c Lubica Ondrušová, Jiri Vachtenheim, Jiri Réda, Petra Žáková, Kamila Benková
520    9_
$a Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGFß2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.
650    _2
$a apoptóza $x genetika $7 D017209
650    _2
$a western blotting $7 D015153
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $7 D049109
650    _2
$a viabilita buněk $x genetika $7 D002470
650    _2
$a chromozomální proteiny, nehistonové $x genetika $x metabolismus $7 D002868
650    _2
$a cyklin-dependentní kinasa 2 $x genetika $x metabolismus $7 D051357
650    _2
$a DNA-helikasy $x genetika $x metabolismus $7 D004265
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a inhibitory apoptózy $x genetika $x metabolismus $7 D051034
650    _2
$a insulinu podobný růstový faktor I $x genetika $x metabolismus $7 D007334
650    _2
$a melanom $x genetika $x metabolismus $x patologie $7 D008545
650    _2
$a transkripční faktor spojený s mikroftalmií $x genetika $x metabolismus $7 D051739
650    _2
$a névus $x genetika $x metabolismus $x patologie $7 D009506
650    _2
$a jaderné proteiny $x genetika $x metabolismus $7 D009687
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a osteopontin $x genetika $x metabolismus $7 D053495
650    _2
$a RNA interference $7 D034622
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a transkripční faktory $x genetika $x metabolismus $7 D014157
650    _2
$a transformující růstový faktor beta2 $x genetika $x metabolismus $7 D053781
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vachtenheim, Jiri $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Réda, Jiri $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Záková, Petra $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Benková, Kamila $u Department of Pathology, Hospital Bulovka, Prague, Czech Republic
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 8, č. 1 (2013), s. e54110
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23349796 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20141223084737 $b ABA008
999    __
$a ok $b bmc $g 995769 $s 830127
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 8 $c 1 $d e54110 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
GRA    __
$a NT11229 $p MZ0
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...